Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 11:50 AM
Ignite Modification Date:
2025-12-25 @ 11:52 AM
NCT ID:
NCT01253161
Group ID:
EG000
Title:
Pasireotide LAR Treatment
Description:
The investigational drug used in this study is pasireotide long acting release (LAR) 60 mg.
Pasireotide Long Acting Release (LAR): Pasireotide will be administered as an intramuscular injection at the beginning of every cycle which is defined as 28 days (+/- 3 days). Study treatment should begin within 14 days following enrollment into the study and continue until disease progression, unacceptable toxicity, or withdrawal of consent.
Deaths Number Affected:
6
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
29
Other Number Affected:
28
Other Number At Risk:
29
Study:
NCT01253161
Results Section:
NCT01253161
Adverse Events Module:
NCT01253161